What is tomosynthesis (tomo) and how is it used with a mammogram?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Tomosynthesis (Tomo) with Mammography?

Tomosynthesis (also called digital breast tomosynthesis or DBT) is a 3D mammography technique that acquires multiple low-dose X-ray images of the breast from different angles, which are then reconstructed into thin-section images—essentially creating a quasi-3D view of the breast that reduces tissue overlap and improves cancer detection compared to standard 2D mammography. 1

How It Works

DBT uses a moving X-ray tube and digital detector to capture images at multiple angles during a single compression. Computer algorithms then reconstruct these images into thin slices (typically 1mm sections) that radiologists can scroll through, similar to viewing a CT scan 1. This eliminates the tissue superimposition problem that plagues standard 2D mammography, where overlapping breast tissue can either hide cancers or create false abnormalities 2.

Clinical Benefits

Cancer Detection

Adding DBT to standard mammography increases cancer detection rates by 1.2 to 3.0 additional cancers per 1,000 women screened 2. The most recent high-quality randomized trial (TOSYMA, 2022) demonstrated a 48% increase in invasive breast cancer detection (odds ratio 1.48) when using DBT plus synthetic 2D images compared to standard digital mammography alone 3. The detected cancers tend to be smaller, less likely to have lymph node involvement, and less biologically aggressive 4.

Reduced False Positives

DBT significantly reduces recall rates (callbacks for additional imaging) by 15-63% in U.S. studies, with absolute reductions ranging from 0.8% to 3.6% 2, 4. This translates to fewer unnecessary callbacks and biopsies. In the Oslo Tomosynthesis Screening Trial, recall rates dropped from 6.7 per 1,000 to 3.6 per 1,000 2. However, this benefit is most pronounced in screening programs with already high baseline recall rates (typical in the U.S.), while European programs with lower baseline recalls may see less dramatic reductions 5.

Radiation Exposure Considerations

A common concern is that combining standard 2D mammography with DBT doubles radiation exposure. However, this combined dose still falls below FDA limits for standard mammography 1. More importantly, newer synthetic 2D mammography (s2D) techniques reconstruct a conventional-looking 2D image from the DBT dataset itself, eliminating the need for a separate 2D acquisition and keeping radiation exposure equivalent to standard mammography alone 1.

Current Recommendations by Clinical Context

Screening in Average-Risk Women

When mammography is performed for screening, tomosynthesis should be considered as an adjunct 1. The ACR Appropriateness Criteria (2025) and NCCN guidelines (2021) support DBT use across all breast density categories, though the benefit is most pronounced in women with heterogeneously dense breasts 4. Women with extremely dense breasts may need additional supplemental screening beyond DBT alone 4.

High-Risk Women

For women with BRCA1/2 mutations or other high-risk conditions, when mammography is performed (typically as an adjunct to MRI), tomosynthesis should be considered 1. For high-risk women under age 30, breast MRI is preferred over mammography due to radiation concerns and superior sensitivity 1.

Diagnostic Setting

DBT improves diagnostic accuracy in symptomatic women and those recalled from screening, reducing the number of indeterminate findings and additional views needed 6, 7, 8. It's particularly valuable for characterizing masses, architectural distortions, and distinguishing true lesions from overlapping tissue 6, 7.

Important Caveats

  • The interval cancer rate data are still pending: While DBT detects more cancers at screening, we're awaiting long-term follow-up studies (like TMIST) to confirm whether this translates to fewer cancers detected between screening rounds and ultimately reduced mortality 4, 9

  • Potential for overdiagnosis: The increased detection rate may include some cancers that would never have caused clinical problems, though detected cancers appear more favorable biologically 9

  • Dense breast limitations: While DBT improves detection in dense breasts compared to 2D mammography alone, women with extremely dense tissue may still benefit from additional screening modalities like ultrasound or MRI 4

  • Interpretation time: Reading DBT images takes longer than standard mammography, though radiologists become more efficient with experience 6

Practical Implementation

Whenever possible, use synthetic 2D/DBT protocols rather than conventional 2D/DBT to minimize radiation exposure 9. The synthetic images perform equivalently to standard 2D mammograms while eliminating the need for double exposure 6.

References

Guideline

acr appropriateness criteria<sup>®</sup> palpable breast masses.

Journal of the American College of Radiology, 2017

Research

Breast tomosynthesis: What do we know and where do we stand?

Diagnostic and interventional imaging, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.